Pubblicazioni presenti sul Catalogo Istituzionale

Elenco delle pubblicazioni

 

La produzione scientifica aggiornata al 1 ottobre 2011 è costituita da circa 102 lavori scientifici.

Essi comprendono: 18 pubblicazioni in extenso su riviste internazionali recensite e con impact factor di cui 5 come primo Autore,  8 come secondo Autore, 5 su riviste nazionali e internazionali senza impact factor ed infine 79 abstracts e comunicazioni orali a congressi Nazionali e Internazionali.

 

 PUBBLICAZIONI SU RIVISTE SENZA IMPACT FACTOR

2008

Falasca K, Ucciferri C, Mancino P, Di Girolamo A, Vecchiet J.
“Infected atrial mixoma: a rare cause of fever”.
Infez Med 16(1): 41-43, 2008.

Mancino P, Ucciferri C, Falasca K, Racciatti D, Di Girolamo A, Vecchiet J, Pizzigallo E.
“Inguinal lymphadenopathy due to Bartonella henselae”.
Infez Med 16(2): 91-93, 2008.

2009

Mancino P, Dalessandro M, Falasca K, Ucciferri C, Pizzigallo E, Vecchiet J.
“Acute urinary retention due to HSV-1: a case report.”
Infez Med17(1): 38-40, 2009.

Mancino P, Falasca K, Ucciferri C, Pizzigallo E, Vecchiet J.
“Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV epatiti. Review”
Medit J Hemat Infect Dis 1; 2009.

2011

“

Ucciferri C,Falasca K, Mancino P, Pizzigallo E, Vecchiet J.

“Proteinuria in an African HIV-infected patient: effects of telmisartan”

Infez Med19(2): 125-7, 2011. 

 

 

PUBBLICAZIONI SU RIVISTE CON IMPACT FACTOR     

2006

Falasca K, Manigrasso MR, Racciatti D, Zingariello P, Dalessandro M, Ucciferri C, Mancino P, Marinopiccoli M, Petrarca C, Conti P, Pizzigallo E, Guagnano MT, Vecchiet J.
“Association between hypertriglyceridemia and serum ghrelin, adiponectin and IL-18 levels in HIV-infected patients”.
Ann Clin Lab Scie 36 (1): 59-66, 2006.                                    

Falasca K, Ucciferri C, Dalessandro M, Zingariello P, Mancino P, Petrarca C, Pizzigallo E, Conti P, Vecchiet J.
“Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C”.
Ann Clin Lab Scie 36 (2): 144--150, 2006.

2007

Falasca K, Ucciferri C, Manzoli L, Mancino P, Pizzigallo E, Conti P, Vecchiet J.
“Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy”
Int J Immunopathol Pharmacol. 20(3): 519-527, 2007.

Falasca K, Mancino P, Ucciferri C, Dalessandro M, Zingariello P, Lattanzio FM, Petrarca C, Martinotti S, Pizzigallo E, Conti P, Vecchiet J.
“Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias”.
Clin Invest Med. 30(5): E167-176, 2007.

Ucciferri C, Falasca K, Mancino P, De Tullio D, Pizzigallo E, Vecchiet J.
“High dose of erythropoietin in management of interferon/ribavirin induced anemia.”
HepatoGastroenterology. 54(80): 2181-2183, 2007.

2008

Mancino P, Ucciferri C, Falasca K, Pizzigallo E, Vecchiet J.
“Methicillin-resistant Staphylococcus epidermidis (MRSE) endocarditis treated with linezolid.”
Scand J Infect Dis. 40(1): 67-73, 2008.

Falasca K, Vecchiet F, Ucciferri C, Vignale F, Conti P, Pizzigallo A, Piattelli A, Vecchiet J.
“Periodontitis and cytokine patterns in HIV positive patients”.
Eur J Med Res 13: 1-6, 2008.

Falasca K, Ucciferri C, Mancino P, Vitacolonna E, De Tullio D, Pizzigallo E, Conti P, Vecchiet J.
“Treatment with silybin-vitamin E-phospholipid complex in patients with hepatitis C infection.”
J Med Virol. 80(11): 1900-1906, 2008.

2009

Falasca K, Mancino P, Ucciferri C, Dalessandro M, Manzoli L, Pizzigallo E, ContiCM, Vecchiet J.
“Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy.”
Clin Invest Med. 32(3): E212-218, 2009.

Falasca K, Ucciferri C, Mancino P, Pizzigallo E, Calza L, Vecchiet J.
“Severe HIV-associated hypertriglyceridemia treated with rosuvastatin plus omega-3 fatty acids.”
Int J STD & AIDS.20(8): 580-581, 2009.

Ucciferri C, Mancino P, Vecchiet J, Falasca K.
“Beneficial effects of telmisartan in HIV+ diabetic insulin-dependent patient.”
Int J Immunopathol Pharmacol. 22(3): 853-858, 2009.

2010

Falasca K, Ucciferri C, Mancino P, Gorgoretti V, Pizzigallo E, Vecchiet J.
“Use of epoetin beta during combination therapy of infection with hepatitis C virus with ribavirin improves a sustained viral response.”
J Med Virol. 82: 49-56, 2010.

Falasca K, Ucciferri C, Mancino P, Di Iorio A, Vignale F, Pizzigallo E, Vecchiet J.
“Cystatin C, adipokines and cardiovascular risk in HIV infected patients”
Curr HIV Res 8: 405-410, 2010.

Teofili L, Iachininoto MG, Capodimonti S, Ucciferri C, Nuzzolo ER, Martini M, Torti L, Falasca K, Vecchiet J, Leone G, Larocca ML.
“Endothelial progenitor cell trafficking in human immunodeficiency virus-infected persons”
AIDS. 2010 Oct 23;24(16):2443-50.

2011

Ucciferri C, Falasca K, Mancino P, Tommasi R, Tatasciore A, Vecchiet J.“Effects of Dual Renin-Angiotensis System Blockade on Proteinuria in a Hypertensive Black"African HIV-Infected Patient” Southern African Journal of HIV Medicine(39), pp. 41-42, 2011

Vecchiet J, Ucciferri C, Falasca K, Mancino P, Di Iorio A, De Caterina R.“Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients”.Antivir Ther16 (5):639-45, 2011.

 Ucciferri C, Falasca K, Mancino P, Di Iorio A, Vecchiet J.“Microalbuminuria and Hypertension in HIV-infected patients: a preliminary study of telmisartan”Eur Rev Med Pharmacol Sci, 2011.in press

 Ucciferri C, Falasca K, Mancino P, Vecchiet J.“Optimization of comorbidity therapy to archive sustained viral response in HCV patients”Hepatogastroentology, 2011.in press